Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-18

Clinical Trial Update: Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating consolidation chemotherapy with concurrent chemoradiotherapy for inoperable Stage III non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Syed Jafri | Conditions: Stage III Non-small Cell Lung Cancer | Phase 2 | Status: WITHDRAWN